Revolutionizing Healthcare | The Cognitive Diagnostics Market's Cutting-Edge Technologies

According to the most recent industry analysis from Future Market Insights, Global Cognitive Diagnostics Market Sales are predicted to reach US$ 110.2 Billion in 2023, with a CAGR of 8.0% over the forecast period, reaching an estimated worth of US$ 238.3 Billion by 2033.

Brain difficulties or cognitive disorders can be caused by closed head injuries, interactions with neurotoxins (toxic substances), genetics, infections, strokes, and tumours. Depending on whether portion of the brain is affected, a person may have a certain type of cognitive difficulty. Communication issues could be caused by a tumour in the brain's speech cisterns, for example. A brain infection that destroys the motor recentres, for example, might cause movement problems. Age has an impact on the development of cognitive impairments.

Wearables and smartphone apps are becoming more popular in cognitive diagnostics. These devices can monitor a patient's cognitive health and send real-time data to medical professionals for more accurate diagnosis and management.

In the market for cognitive diagnostics, collaboration and collaborations between academic institutions, technological firms, and healthcare providers are increasing. Collaborations like these can foster creativity, provide access to technology and approaches for identifying cognitive deficits, and hasten the discovery of novel treatments for these illnesses. For example, in June 2022, the Davos Alzheimer's Collaborative awarded Avant Institute, in partnership with COGNIVUE, a grant to build an innovative Alzheimer's disease early detection programme.

Key Players

  • Cognetivity Neurosciences
  • Cognivue, Inc.
  • Cogstate Ltd.
  • Cambridge Cognition Ltd.
  • Diadem srl
  • CN Diagnostics

Get More Insights@ https://www.futuremarketinsights.com/reports/cognitive-diagnostics-market

Key Market Segments Covered in the Cognitive Diagnostics Industry Research

Diagnosis:

  • Brain Imaging Tests
    • Magnetic Resonance Imaging (MRI)
    • Computerized Tomography (CT)
    • Positron Emission Tomography (PET) and PET/CT
  • Laboratory Testing
    • Cerebrospinal fluid (CSF)
    • Blood Tests
  • Mental Status Testing
    • Mini-Mental State Exam (MMSE)
    • Montreal Cognitive Assessment (MoCA)
  • Rapid Home Screening Tests
  • Neuropsychological Testing
  • Electroencephalogram (EEG)
  • Cognitive Function & Behavioral Tests
  • Neuropsychiatric Inventory Questionnaire (NPI-Q)

Indication:

  • Alzheimer’s disease
  • Attention deficit/hyperactivity disorder
  • Dementia
  • Epilepsy-Related Cognitive Dysfunction
  • Mild Cognitive Impairment
  • Parkinson’s Disease-related Cognitive Dysfunction
  • Stroke-related Cognitive Dysfunction
  • Traumatic Brain Injury
  • Others

End User:

  • Hospitals
  • Neurology Clinics
  • Cognitive Behavioral Therapy Centers
  • Rehabilitation Centers
  • Academic and Research Institutes
  • Diagnostic Imaging Centers
  • Home Care Settings

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more